VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
Memo Therapeutics AG’s CHF20 Million Additional Series C Financing Round
EnBW’s Partnership With Narrowin GmbH
VISCHER advised narrowin GmbH on all aspects on this transaction. The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity start-up....